Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of neurological disorders
3.2.1.2 Increasing advancements in biomarker discovery technologies
3.2.1.3 Rising government initiatives and policies
3.2.1.4 Increasing use of CNS biomarkers
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with CNS biomarker tests and diagnostics
3.2.2.2 Stringent regulatory scenario
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Biomarker Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Safety biomarker
5.3 Efficacy biomarker
5.4 Validation biomarker
5.5 Other biomarkers
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Disease diagnosis
6.3 Drug discovery and development
6.4 Personalized medicines
6.5 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals & clinics
7.3 Diagnostic laboratories
7.4 Academic & research institutes
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 bioMerieux
9.2 Bio-Rad Laboratories, Inc.
9.3 F. Hoffmann-La Roche Ltd
9.4 G-Biosciences
9.5 Illumina, Inc.
9.6 Merck KGaA
9.7 Myriad Genetics, Inc.
9.8 Novartis AG
9.9 PerkinElmer Inc.
9.10 Siemens Healthineers AG
9.11 Sysmex Corporation
9.12 Thermo Fisher Scientific Inc.
